AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2022
May 9, 2022
35200_dirs_2022-05-09_7ce40e3d-e99c-4b40-8d23-e5a15ce842c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2022-05-05
Reporting Person: Lamb Lawrence (EVP and CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-05 | Common Stock | M | 26204 | $1.0685 | Acquired | 99204 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-05-05 | Employee Stock Option (right to buy) | $1.0685 | M | 26204 | Disposed | 2028-11-11 | Common Stock (26204) | Direct |
Footnotes
F1: The shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments commencing June 7, 2018, subject to the Reporting Person continuing to provide service through each such date.